Literature DB >> 15286267

Pertussis pneumonia, hypoxemia, hyperleukocytosis, and pulmonary hypertension: improvement in oxygenation after a double volume exchange transfusion.

Michael J Romano1, Mark D Weber, Martin E Weisse, Benjamin L Siu.   

Abstract

A 3-month-old infant of 33 weeks' gestation was hospitalized with pneumonia caused by Bordetella pertussis. Respiratory insufficiency worsened, and on hospital day 3, there was severe pulmonary dysfunction (arterial oxygen pressure/fraction of inspired oxygen ratio: 120), extreme leukocytosis (white blood cell count 104,000/mm3), and severe pulmonary hypertension as assessed by 2-dimensional echocardiogram. A double volume exchange transfusion was performed to reduce the leukocyte mass. Oxygenation began to improve during the exchange and continued to improve over the ensuing 31 hours (arterial oxygen pressure/fraction of inspired oxygen ratio: 280). The white blood cell count fell dramatically after the exchange, and the rate of rise was slower after exchange therapy compared with preexchange.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286267     DOI: 10.1542/peds.114.2.e264

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

1.  Hyperleukocytosis: emergency management : authors' reply.

Authors:  Deepak Bansal; Richa Jain
Journal:  Indian J Pediatr       Date:  2013-06-06       Impact factor: 1.967

Review 2.  Diagnosis and management of pertussis.

Authors:  Alberto E Tozzi; Lucia Pastore Celentano; Marta Luisa Ciofi degli Atti; Stefania Salmaso
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

3.  Exchange transfusion for hemolytic hyperbilirubinemia: could some be averted by emergent administration of an inhibitor of bilirubin production?

Authors:  Susan E Wiedmeier; Timothy M Bahr; Robin K Ohls; Thomas R Christensen; Vickie L Baer; Sarah J Ilstrup; Kelly Cail; Robert D Christensen
Journal:  J Perinatol       Date:  2020-07-15       Impact factor: 2.521

Review 4.  Pertussis leukocytosis: mechanisms, clinical relevance and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2016-09-07       Impact factor: 3.166

Review 5.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 6.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

7.  Pertussis requiring intensive care.

Authors:  Julia Surridge; Elizabeth R Segedin; Cameron C Grant
Journal:  Arch Dis Child       Date:  2007-07-04       Impact factor: 3.791

Review 8.  Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.

Authors:  Abdulbaset M Salim; Yan Liang; Paul E Kilgore
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

Review 9.  The Collaborative Pediatric Critical Care Research Network Critical Pertussis Study: collaborative research in pediatric critical care medicine.

Authors:  Jeri S Burr; Tammara L Jenkins; Rick Harrison; Kathleen Meert; K J S Anand; John T Berger; Jerry Zimmerman; Joseph Carcillo; J Michael Dean; Christopher J L Newth; Douglas F Willson; Ronald C Sanders; Murray M Pollack; Eric Harvill; Carol E Nicholson
Journal:  Pediatr Crit Care Med       Date:  2011-07       Impact factor: 3.624

10.  Malignant pertussis in infants: factors associated with mortality in a multicenter cohort study.

Authors:  Mathilde Coquaz-Garoudet; Dominique Ploin; Robin Pouyau; Yoav Hoffmann; Julien-Frederic Baleine; Benoît Boeuf; Hugues Patural; Anne Millet; Marc Labenne; Renaud Vialet; Didier Pinquier; Marie Cotillon; Jérôme Rambaud; Etienne Javouhey
Journal:  Ann Intensive Care       Date:  2021-05-07       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.